The Year Ahead: Hard Times For Indian Generics May Force Switch To Innovation
This article was originally published in PharmAsia News
Executive Summary
Paucity of blockbuster off-patent opportunities is pressing Indian drug makers to grab technology-led products or devices to secure future growth.